Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-01-02$20.09/sh−2,777$55,802→ 2,130 total
Holdings
- 97,058(indirect: See Footnote)
Common Stock
- 1,015,766(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 29, 2023.
- [F2]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F3]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F4]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.